A major advance in cancer research is occurring with the use of nanobodies to re-engage dysfunctional p53. This vital malignant protector protein is frequently disabled in several kinds of cancer, leading uncontrolled https://icelisting.com/story23263462/vhh-fragments-revive-the-p53-protein-a-promising-approach-for-tumor-management